Covirabio GmbH

📍 Vienna, Austria🗓 Founded 2020👥 5 employees
Biotechnology Research🌐 covirabio.net
Website LinkedIn
Covirabio GmbH is a young Start-Up company with the vision to enable pathogen detection and immune monitoring at the Point-of-Care or Point-of-Need. Based on the Covirabio technology platform VERB (Virus Entry Receptor Binding), a portfolio of test systems for the detection of SARS-CoV-2 infections or the immune response to an infection and/or vaccination is currently being developed. For the use at the Point-of-Care or Point-of-Need, the assays are integrated into microfluidic systems. This technology platform is now also expanded to bacterial pathogens.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Covirabio GmbH founded?
Covirabio GmbH was founded in 2020.
What industry is Covirabio GmbH in?
Covirabio GmbH operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Covirabio GmbH based?
Covirabio GmbH is headquartered in Vienna, Austria.